Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TALIGLUCERASE ALFA vs TAPENTADOL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TALIGLUCERASE ALFA vs TAPENTADOL: Safety Overview

Metric TALIGLUCERASE ALFA TAPENTADOL
Total FAERS Reports 453 29,208
Deaths Reported 48 20,205
Death Rate 10.6% 69.2%
Hospitalizations 92 3,304
Average Patient Age 52.2 yrs 58.0 yrs
% Female Patients 38.1% 60.1%
FDA Approval Date N/A Aug 25, 2011
Manufacturer Pfizer Laboratories Div Pfizer Inc Collegium Pharmaceutical, Inc.
Route INTRAVENOUS ORAL
Marketing Status Prescription Prescription